Welcome to our dedicated page for Check Cap news (Ticker: CHEK), a resource for investors and traders seeking the latest updates and insights on Check Cap stock.
Check-Cap Ltd. (CHEK) is a clinical-stage innovator in non-invasive screening, developing the C-Scan® ingestible capsule for colorectal cancer detection. This page provides investors and medical professionals with essential updates on the company's advancements in patient-friendly diagnostic technology.
Access authoritative updates on clinical trial progress, regulatory milestones, and strategic partnerships. Our curated news collection focuses on developments directly impacting Check-Cap's position in preventive healthcare solutions, including technological refinements to its low-dose X-ray imaging system.
Key updates cover FDA communications, trial phase results, and collaborations with healthcare institutions. All content is verified through primary sources to ensure accuracy for investment and research decisions.
Bookmark this page for streamlined access to Check-Cap's evolving role in transforming colorectal screening through preparation-free technology. Monitor critical developments in medical imaging innovation and diagnostic accessibility.
Check-Cap (NASDAQ:CHEK) has entered into a definitive merger agreement with MBody AI, creating a combined company focused on embodied AI for the autonomous workforce. Under the agreement, MBody AI shareholders will own 90% of the combined company, while Check-Cap shareholders will retain 10% on a fully diluted basis.
The merged entity, to be renamed MBody AI Ltd., will operate in the embodied-AI market, which Morgan Stanley forecasts to reach $40 Trillion by 2050. MBody AI specializes in developing proprietary AI technology for intelligent systems, initially focusing on hospitality with plans to expand into warehousing, office management, and healthcare. Check-Cap's legacy business, including patents and proprietary medical equipment, will continue as part of the combined company.
The merger requires Check-Cap shareholder approval at the October 17, 2025 Annual General Meeting. Additionally, Check-Cap must address a Nasdaq compliance issue regarding minimum stockholders' equity by October 20, 2025.
FAQ
What is the current stock price of Check Cap (CHEK)?
What is the market cap of Check Cap (CHEK)?
